Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma

Br J Haematol. 2018 Dec;183(5):812-815. doi: 10.1111/bjh.15026. Epub 2017 Nov 16.

Authors

Benedetta Dalla Palma^{1

2}, Valentina Marchica¹, Mario Pedrazzoni^{1

3}, Fabrizio Accardi^{1

2}, Laura Notarfranchi^{1

2}, Matteo Goldoni¹, Federica De Luca^{1

2}, Federica Costa¹, Paola Storti¹, Denise Toscani¹, Gabriella Sammarelli², Sabrina Bonomini², Franco Aversa^{1

2}, Nicola Giuliani^{1

2}

Affiliations

¹ Department of Medicine and Surgery, University of Parma, Parma, Italy.
² Haematology and BMT Centre, "Azienda Ospedaliero-Universitaria di Parma", Parma, Italy.
³ "Clinica e Terapia Medica", "Azienda Ospedaliero-Universitaria di Parma", Parma, Italy.

PMID: 29143308
DOI: 10.1111/bjh.15026

No abstract available

Keywords: cytokines; multiple myeloma; risk factors; smouldering myeloma; tumoural progression.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers / metabolism
Bone Marrow / chemistry*
Disease Progression
Humans
Intercellular Signaling Peptides and Proteins / metabolism*
Risk Factors
Smoldering Multiple Myeloma / metabolism
Smoldering Multiple Myeloma / mortality*

Substances

Biomarkers
DKK1 protein, human
Intercellular Signaling Peptides and Proteins